Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02067962Completed
Single-arm trial, sponsored by CHU Montpellier. Primary endpoint: Identification of new genes by Next Generation Squencing (NGS) at 1 day. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02067962.